UBS O'Connor’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-39,671
Closed -$1.11M 525
2023
Q3
$1.11M Sell
39,671
-65,400
-62% -$2.25M 0.02% 320
2023
Q2
$3.88M Buy
+105,071
New +$3.21M 0.08% 156
2022
Q4
Sell
-112,121
Closed -$2.76M 60
2022
Q3
$2.76M Sell
112,121
-81,373
-42% -$2.68M 0.03% 463
2022
Q2
$6.2M Buy
+193,494
New +$7.12M 0.06% 186
2022
Q1
Sell
-348,443
Closed -$11.7M 32
2021
Q4
$11.7M Buy
348,443
+6,975
+2% +$217K 0.11% 79
2021
Q3
$9.92M Sell
341,468
-80,273
-19% -$2.6M 0.08% 114
2021
Q2
$14.7M Sell
421,741
-213,770
-34% -$7.08M 0.13% 75
2021
Q1
$17.7M Buy
635,511
+493,909
+349% +$13.1M 0.26% 51
2020
Q4
$3.51M Buy
+141,602
New +$3.37M 0.07% 292
2018
Q1
Sell
-28,118
Closed -$1.41M 309
2017
Q4
$1.41M Sell
28,118
-26,193
-48% -$1.37M 0.02% 220
2017
Q3
$2.75M Buy
+54,311
New +$2.56M 0.04% 241

Other funds holding CC

UBS O'Connor's CC Position: Q4 2023 in Review

UBS O'Connor sold out of Chemours (CC) in Q4 2023, closing a stake of 39,671 shares — an estimated $1.11M sold.

UBS O'Connor first reported a position in CC in Q3 2017 and held it in 11 quarters. The position peaked at $17.7M in Q1 2021. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

  • UBS O'Connor reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 39,671 Chemours shares in Q4 2023, an estimated $1.11M.
  • UBS O'Connor first reported a position in Chemours in Q3 2017 and held it in 11 quarters.
  • UBS O'Connor's Chemours position peaked at $17.7M in Q1 2021.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.